Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
Apolipoprotein E
DOI:
10.1016/j.cell.2024.10.027
Publication Date:
2024-11-11T15:36:28Z
AUTHORS (42)
ABSTRACT
While apolipoprotein E (APOE) is the strongest genetic modifier for late-onset Alzheimer's disease (LOAD), molecular mechanisms underlying isoform-dependent risk and relevance of ApoE-associated lipids remain elusive. Here, we report that impaired low-density lipoprotein (LDL) receptor (LDLR) binding lipidated ApoE2 (lipApoE2) avoids LDLR recycling defects observed with lipApoE3/E4 decreases uptake cholesteryl esters (CEs), which are linked to neurodegeneration. In human neurons, addition ApoE carrying polyunsaturated fatty acids (PUFAs)-CE revealed an allelic series (ApoE4 > ApoE3 ApoE2) associated lipofuscinosis, age-related lysosomal pathology resulting from lipid peroxidation. Lipofuscin increased accumulation tau fibrils was elevated in APOE4 mouse brain exacerbation by pathology. Intrahippocampal injection PUFA-CE-lipApoE4 sufficient induce lipofuscinosis wild-type mice. Finally, protective Christchurch mutation also reduced phenocopied ApoE2. Collectively, our data strongly suggest decreased lipApoE-LDLR interactions minimize LOAD reducing deleterious effects endolysosomal targeting pathogenic lipids.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (103)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....